Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion type Assertion NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_head.
- NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion description "[To assess the utility of cytokeratin (CK) profile and albumin mRNA detection (as revealed by in situ hybridization) in the differential diagnosis of primary liver carcinomas (PLCs) we evaluated a series of surgically resected PLCs, comprising 20 'pure' hepatocellular carcinomas (HCCs) (10 well-differentiated, 10 poorly differentiated), 15 cholangiocarcinomas (CCs) (6 peripheral, 5 hilar, and 4 major duct ones) and 10 hepatocholangio-carcinomas (HCC-CCs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_provenance.
- NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion evidence source_evidence_literature NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_provenance.
- NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion SIO_000772 8666372 NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_provenance.
- NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion wasDerivedFrom befree-20150227 NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_provenance.
- NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_assertion wasGeneratedBy ECO_0000203 NP233309.RACDl4ap2zW_o-vKl19nTkuk6ZYMc-8MPa_Ej3BE6Y3fk130_provenance.